Dialog Box

Loading...

Clinical Trials

Current Trials Open to Recruitment | How do I become involved in a clinical trial? 

 

The Skin & Cancer Foundation Inc's Clinical Trials Department has been responsible for numerous clinical trials over the years.

 

The research activities of the Clinical Trials Department are supervised and coordinated by specialist dermatologist, Associate Professor Peter Foley, assisted by Associate Professor Chris Baker, Associate Professor Alvin Chong and Dr Maree Micallef.

 

Learn more about the Clinical Trials Team  

 

The Clinical Trials Department has been involved in over 70 clinical trials in the last 20 years. Many of these trials have led to life-changing treatments used for a wide range of conditions including skin cancer, psoriasis and rosacea.

 

Successful treatments approved for use in Australia, which were tested by our Clinical Trials Department include:

 

Drug/Treatment  Condition 
Aldara  Basal cell carcinoma; Actinic Keratosis 
PDT Metvix & Daylight PDT  Actinic Keratosis; Superficial basal cell carcinoma 
Humira  Psoriasis; Hidradenitis suppurativa 
Soolantra  Rosacea 
Enbrel  Psoriasis; Psoriatic Arthritis 
Picato  Actinic Keratosis 
Secukinumab  Psoriasis 
Apremilast Psoriasis 
 

Current Clinical Trials Now Recruiting 

 

If you would like to learn more about any of the studies currently being conducted at the Skin & Cancer Foundation Inc, please contact the nominated study coordinator.

 

If you have any general questions regarding the clinical trials conducted at the Foundation, please feel free to contact the Clinical Trials Department at trials@skincancer.asn.au

 

TOPICAL MEDICATION STUDY FOR FACIAL ACNE (17 WEEKS)

Individuals who are 12 to 40 years of age with moderate to severe facial acne, may qualify to receive investigational topical medication (active drug) or placebo.

 

To be eligible, participants must have 20-50 red, irritated pimples; 20-100 whiteheads or blackheads; and no more than 2 large, hard bumps on the face. If you qualify, you will have regular visits with an experienced research team. There is no cost to participate, and participants will receive payment for travel and other study-related expenses.

 

Participants will be asked to visit the study centre about 6 times over a period of about 17 weeks.

 

For more information, please contact:

 

Principal Investigator:


A/Prof Peter Foley

 

Sub Investigator:
Dr Isaac Lee
t: 9623 9400
e: slee@skincancer.asn.au

 

Study Coordinator:
Charlotte Harrison-Mullan
t: 9623 9470
e: charrison@skincancer.asn.au

 

ATOPIC DERMATITIS RESEARCH STUDY (20 WEEKS)

Individuals 12 years of age or older diagnosed with chronic atopic dermatitis (eczema) for at least 1 year, may qualify to receive investigational oral study medication (active drug) or placebo (inactive drug).

To be eligible, participants must have had an inadequate response to treatment with topical medication. Moderate to severe disease severity must be present at the time of study entry. Qualified participants will have regular visits with an experienced research team. Participation will last up to 20 weeks.

There is no cost to participate, and participants will be reimbursed for study-related expenses.

For more information, please contact:

Principal Investigator:

A/Prof Peter Foley

 

Sub Investigator:

Dr Isaac Lee

t: 9623 9400

e: slee@skincancer.asn.au

Study Coordinator:

Tracy Mallett

t: 9623 9406

e: tmallett@skincancer.asn.au

 

PLAQUE PSORIASIS COMPARATOR STUDY (68 WEEKS)

People who are 18 years of age or older with chronic plaque psoriasis for at least 6 months, may qualify to receive investigational medication (active drug), active comparator or placebo via subcutaneous injection.

To be eligible, participants must have psoriasis that covers 10% or more of their body surface area (or an area equal to 10 hand-sized patches). Moderate to severe disease severity must be present at the time of study entry. If you qualify, you will have regular visits with an experienced research team. There is no cost to participate, and participants will be reimbursed for study-related expenses.

 

Participants will be asked to visit the study centre about 18 times over a period of up to 68 weeks.

 

 For more information, please contact:

Principal Investigator:

 

A/Prof Peter Foley

 

Sub Investigator:

Dr Isaac Lee

t: 9623 9400

e: slee@skincancer.asn.au 

 

Study Coordinator:

Charlotte Harrison-Mullan

t: 9623 9470

e: Charrison@skincancer.asn.au 

How do I become involved in a clinical trial at the Foundation?

 

Anyone wishing to participate in a clinical trial may potentially be eligible. A referral from a clinical is not necessary.

 

Contact the Clinical Trials Department directly to enquire about current research projects to determine your suitability. 

 

Phone: (03) 9623 9416

Email: trials@skincancer.asn.au

 

 

Back to top 

 

Support Our Research
Thank you for helping the Skin & Cancer Foundation continue its groundbreaking research in to skin cancer and health!
Stay In Touch
Email address is required.
Submit